Literature DB >> 3089905

Incidence of gonorrhoea due to penicillinase producing Neisseria gonorrhoeae in Japan 1981-3 and treatment using a new antibiotic combination, BRL25000 (amoxycillin and clavulanic acid).

K Osato, H Tsugami, K Harada, J Maruyama.   

Abstract

During the three years 1981-3, 134 (9.1%) of 1473 patients presenting at our clinics were found to be infected with penicillinase producing strains of Neisseria gonorrhoeae (PPNG). Minimum inhibitory concentrations (MICs) of benzylpenicillin and ampicillin against these PPNG strains were 8 mg/l or more, whereas against non-PPNG strains they were consistently 4 mg/l or less. In contrast, the MIC of BRL25000 (two parts amoxycillin and one part clavulanic acid, the beta lactamase inhibitor) was 4 mg/l or less even against PPNG strains. MICs of a number of other drugs commonly used to treat gonorrhoea, such as cephaloridine, cefoxitin, tetracycline, doxycycline, minocycline, kanamycin, and spectinomycin, showed no appreciable differences between non-PPNG and PPNG strains and the MIC of cephaloridine in particular was relatively high. BRL25000 proved to be very effective in the treatment of PPNG infection and cured all of 121 patients treated. A daily dose of 2.25g, cured 105 patients in two days, 11 patients in three days, four patients in four days, and one patient in five days. A new rapid diagnostic method for detecting PPNG strains, capable of application at an outpatient clinic and providing a result on the following day, is described.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089905      PMCID: PMC1011927          DOI: 10.1136/sti.62.3.158

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  5 in total

1.  Antibiotic sensitivity patterns of penicillinase-positive and penicillinase-negative strains of Neisseria gonorrhoeae isolated in Fukuoka, Japan.

Authors:  S Yoshida; S Urabe; Y Mizuguchi
Journal:  Br J Vener Dis       Date:  1982-10

2.  Penicillinase-producing Neisseria gonorrhoeae.

Authors:  W A Ashford; R G Golash; V G Hemming
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

3.  Inhibition of beta-lactamase in Neisseria gonorrhoeae by sodium clavulanate.

Authors:  J M Miller; C N Baker; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

4.  Two dose Augmentin treatment of acute gonorrhoea in men.

Authors:  K B Lim; V S Rajan; Y C Giam; E O Lui; E H Sng; K L Yeo
Journal:  Br J Vener Dis       Date:  1984-06

5.  Treating gonococcal urethritis in men: oral amoxycillin potentiated by clavulanate compared with intramuscular procaine penicillin.

Authors:  A S Latif; J Sithole; S Bvumbe; B Gumbo; M Kawemba; R S Summers
Journal:  Br J Vener Dis       Date:  1984-02
  5 in total
  3 in total

Review 1.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 2.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

3.  Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinations.

Authors:  P C Fuchs; A L Barry; C N Baker; P R Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.